Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 36c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $30.71 --0%
EPS Growth %: -27.8%
Financial Fact:
Selling, general and administrative: 1.89M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: -27.8%
Financial Fact:
Selling, general and administrative: 1.89M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q1 EPS of ($1.69), $0.36 worse than the analyst estimate of ($1.33).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- SmartRent (SMRT) Reports In-Line Q3 EPS
- Medline Inc. (MDLN) Reports Q3 EPS of $0.44
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
